Baglia Michelle L, Zheng Wei, Li Honglan, Yang Gong, Gao Jing, Gao Yu-Tang, Shu Xiao-Ou
Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
Department of Epidemiology, Shanghai Cancer Institute, Shanghai, People's Republic of China.
Int J Cancer. 2016 Aug 15;139(4):742-8. doi: 10.1002/ijc.30117. Epub 2016 May 5.
Soy food intake has previously been associated with reduced breast cancer risk. Epidemiological evidence for subgroups of breast cancer, particularly by menopausal and hormone receptor status, is less consistent. To evaluate the role of hormone receptor and menopausal status on the association between soy food intake and breast cancer risk, we measured usual soy food intake in adolescence and adulthood via food frequency questionnaire in 70,578 Chinese women, aged 40-70 years, recruited to the Shanghai Women's Health Study (1996-2000). After a median follow-up of 13.2 years (range: 0.01-15.0), 1,034 incident breast cancer cases were identified. Using Cox models, we found that adult soy intake was inversely associated with breast cancer risk [hazard ratio (HR) for fifth versus first quintile soy protein intake = 0.78; 95% confidence interval (CI):0.63-0.97]. The association was predominantly seen in premenopausal women (HR = 0.46; 95% CI:0.29-0.74). Analyses further stratified by hormone receptor status showed that adult soy intake was associated with significantly decreased risk of estrogen receptor (ER)+/progesterone receptor (PR)+ breast cancer in postmenopausal women (HR = 0.72; 95% CI:0.53-0.96) and decreased risk of ER-/PR- breast cancer in premenopausal women (HR = 0.46; 95% CI:0.22-0.97). The soy association did not vary by human epidermal growth factor-2 (HER2) status. Furthermore, we found that high soy intake during adulthood and adolescence was associated with reduced premenopausal breast cancer risk (HR = 0.53; 95% CI: 0.32-0.88; comparing third vs. first tertile) while high adulthood soy intake was associated with postmenopausal breast cancer only when adolescent intake was low (HR = 0.63; 95% CI: 0.43-0.91). Our study suggests that hormonal status, menopausal status and time window of exposure are important factors influencing the soy-breast cancer association.
此前,大豆类食物的摄入与降低乳腺癌风险有关。关于乳腺癌亚组,尤其是按绝经状态和激素受体状态划分的亚组的流行病学证据,其一致性较差。为了评估激素受体和绝经状态在大豆类食物摄入与乳腺癌风险关联中的作用,我们通过食物频率问卷,对纳入上海女性健康研究(1996 - 2000年)的70578名40至70岁中国女性,测量了她们在青春期和成年期的大豆类食物通常摄入量。经过中位随访13.2年(范围:0.01 - 15.0年),共识别出1034例新发乳腺癌病例。使用Cox模型,我们发现成年期大豆摄入量与乳腺癌风险呈负相关[大豆蛋白摄入量第五分位数与第一分位数相比的风险比(HR)= 0.78;95%置信区间(CI):0.63 - 0.97]。这种关联主要见于绝经前女性(HR = 0.46;95% CI:0.29 - 0.74)。按激素受体状态进一步分层分析显示,成年期大豆摄入量与绝经后女性雌激素受体(ER)+/孕激素受体(PR)+乳腺癌风险显著降低相关(HR = 0.72;95% CI:0.53 - 0.